Skip to content

Synergy Pharma downgraded to sell by Citi

April 6, 2017

Citi downgraded Synergy Pharmaceuticals (NASDAQ: SGYP) from Neutral to Sell.

Analyst Liav Abraham says the attractiveness of the company as a takeout target has diminished following the recent launch of Trulance.

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: